Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seeman

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
ACS Chemical Neuroscience|April 12, 2021
The High Affinity Dopamine D<sub>2</sub> Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological DisordersSivan Subburaju, Anna W Sromek, Philip Seeman, et al.
Synapse (New York, N.Y.)|February 3, 2009
Rats with persistently high exploratory activity have both higher extracellular dopamine levels and higher proportion of D(2) (High) receptors in the striatumAet Alttoa, Philip Seeman, Kadri Kõiv, et al.
Synapse (New York, N.Y.)|October 10, 2002
Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challengesPhilip Seeman, Teresa Tallerico, Françoise Ko, et al.
Synapse (New York, N.Y.)|August 10, 2005
Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptorsPhilip Seeman, Françoise Ko, Matthäus Willeit, et al.
Synapse (New York, N.Y.)|February 24, 2007
Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brainPhilip Seeman, Françoise Ko, Elaine Jack, et al.
ACS Omega|June 8, 2026
Characterization of [<sup>3</sup>H]MCL-524, a Potent Dopamine D<sub>2</sub> <sup>high</sup> Receptor AgonistSivan Subburaju, Anna W Sromek, Philip Seeman, et al.
ACS Chemical Neuroscience|April 12, 2018
New Dopamine D2 Receptor Agonist, [<sup>3</sup>H]MCL-536, for Detecting Dopamine D2high Receptors in VivoSivan Subburaju, Anna W Sromek, Philip Seeman, et al.
Synapse (New York, N.Y.)|December 17, 2008
Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNOPhilip Seeman, Giuseppe Battaglia, Corrado Corti, et al.
Nuclear Medicine and Biology|December 27, 2007
Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivoPatrick N McCormick, Shitij Kapur, Philip Seeman, et al.
Synapse (New York, N.Y.)|April 21, 2007
Elevated dopamine D2High receptors in alpha-1b-adrenoceptor knockout supersensitive miceJean-Pol Tassin, Yvette Torrens, Lucas Salomon, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
ACS Chemical Neuroscience|April 12, 2021
The High Affinity Dopamine D<sub>2</sub> Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological DisordersSivan Subburaju, Anna W Sromek, Philip Seeman, et al.
Synapse (New York, N.Y.)|February 3, 2009
Rats with persistently high exploratory activity have both higher extracellular dopamine levels and higher proportion of D(2) (High) receptors in the striatumAet Alttoa, Philip Seeman, Kadri Kõiv, et al.
Synapse (New York, N.Y.)|October 10, 2002
Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challengesPhilip Seeman, Teresa Tallerico, Françoise Ko, et al.
Synapse (New York, N.Y.)|August 10, 2005
Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptorsPhilip Seeman, Françoise Ko, Matthäus Willeit, et al.
Synapse (New York, N.Y.)|February 24, 2007
Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brainPhilip Seeman, Françoise Ko, Elaine Jack, et al.
ACS Omega|June 8, 2026
Characterization of [<sup>3</sup>H]MCL-524, a Potent Dopamine D<sub>2</sub> <sup>high</sup> Receptor AgonistSivan Subburaju, Anna W Sromek, Philip Seeman, et al.
ACS Chemical Neuroscience|April 12, 2018
New Dopamine D2 Receptor Agonist, [<sup>3</sup>H]MCL-536, for Detecting Dopamine D2high Receptors in VivoSivan Subburaju, Anna W Sromek, Philip Seeman, et al.
Synapse (New York, N.Y.)|December 17, 2008
Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNOPhilip Seeman, Giuseppe Battaglia, Corrado Corti, et al.
Nuclear Medicine and Biology|December 27, 2007
Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivoPatrick N McCormick, Shitij Kapur, Philip Seeman, et al.
Synapse (New York, N.Y.)|April 21, 2007
Elevated dopamine D2High receptors in alpha-1b-adrenoceptor knockout supersensitive miceJean-Pol Tassin, Yvette Torrens, Lucas Salomon, et al.
Pageof 9